Staphylococcus aureus subsp. aureus Rosenbach (ATCC® 55804)

Strain Designations: Serotype 336  /  Type Strain: no  /  Biosafety Level: 2

Deposited As Staphylococcus aureus Rosenbach
Strain Designations Serotype 336
Application
Used to produce vaccine
Enteric Research
Isolation
Urine
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype 336 (Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998)
Product Format freeze-dried
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol® no
Type Strain no
Antigenic Properties Serotype 336 (Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998)
Medium ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37.0°C
Atmosphere: Aerobic
Name of Depositor NABI
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Isolation
Urine
References

Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998

NABI, personal communication

Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998

Fattom AI, Patel AI. Staphylococcus aureus B-linked hexosamine antigen. US Patent 5,770,208 dated Jun 23 1998